Novartis updates US label on Gilenya® following discussions with the FDA

Novartis announced agreement with the US Food and Drug Administration (FDA) on label changes for Gilenya® (fingolimod). The update to the Gilenya prescribing information includes patient selection…
Read the full story: Breaking World Pharma News